Patent ID: 11919967
Assignee: ALZHEIMUR 2012 S.L.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 1:
2. The pharmaceutical composition according to claim 1, wherein the cancer is selected from the group consisting of lung cancer, non-small cell lung cancer, small cell lung cancer, bone cancer, pancreatic cancer, skin cancer, head or neck cancer, cutaneous melanoma, uterine cancer, ovarian cancer, rectal cancer, gastric cancer, colon cancer, breast cancer, Fallopian tube carcinoma, endometrial carcinoma, cervical carcinoma, vaginal carcinoma, vulvar carcinoma, esophageal cancer, small intestine cancer, urethral cancer, prostate cancer, bladder cancer, kidney or ureter cancer, renal cell carcinoma, central and peripheral nervous system tumors, spinal cord tumors, brainstem glioma, glioblastoma multiforme, astrocytoma, medulloblastomas, meningiomas and squamous cell carcinoma.